Skip to content

Heidelberg Pharma (Germany)

Request correction

Corporate brand

Unclaimed

A German pharmaceutical company developing novel cancer treatments based on its ADC technologies.

Last updated September 1, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

Heidelberg Pharma AG is a German company that develops novel drugs for tailored and highly effective cancer treatment based on its ADC technologies. The company uses the highly potent toxin Amanitin from the death cap mushroom, coupling it to specific antibodies to deliver the toxin to tumor cells. It aims to create innovative cancer therapies that are more effective and have fewer side effects than conventional therapies.

History

Heidelberg Pharma AG is a company in Ladenburg, Germany. It develops novel drugs for tailored and highly effective cancer treatment based on its ADC technologies. The company uses the highly potent toxin Amanitin from the death cap mushroom, coupling it to specific antibodies to deliver the toxin to tumor cells. It aims to create innovative cancer therapies that are more effective and have fewer side effects than conventional therapies.

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/heidelberg-pharma-germany · Editorial policy · How profiles are compiled